These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
166 related articles for article (PubMed ID: 35054028)
1. On the Use of Hemadsorption with CytoSorb in Patients with Septic Shock. Comment on Kogelmann et al. First Evaluation of a New Dynamic Scoring System Intended to Support Prescription of Adjuvant CytoSorb Hemoadsorption Therapy in Patients with Septic Shock. Supady A; Lepper PM; Duerschmied D; Wengenmayer T J Clin Med; 2022 Jan; 11(2):. PubMed ID: 35054028 [TBL] [Abstract][Full Text] [Related]
2. Reply to Supady et al. On the Use of Hemadsorption with CytoSorb in Patients with Septic Shock. Comment on "Kogelmann et al. First Evaluation of a New Dynamic Scoring System Intended to Support Prescription of Adjuvant CytoSorb Hemoadsorption Therapy in Patients with Septic Shock. Kogelmann K; Hübner T; Schwameis F; Drüner M; Scheller M; Jarczak D J Clin Med; 2022 Feb; 11(5):. PubMed ID: 35268285 [TBL] [Abstract][Full Text] [Related]
3. First Evaluation of a New Dynamic Scoring System Intended to Support Prescription of Adjuvant CytoSorb Hemoadsorption Therapy in Patients with Septic Shock. Kogelmann K; Hübner T; Schwameis F; Drüner M; Scheller M; Jarczak D J Clin Med; 2021 Jun; 10(13):. PubMed ID: 34209001 [TBL] [Abstract][Full Text] [Related]
4. Use of a novel hemoadsorption device for cytokine removal as adjuvant therapy in a patient with septic shock with multi-organ dysfunction: A case study. Basu R; Pathak S; Goyal J; Chaudhry R; Goel RB; Barwal A Indian J Crit Care Med; 2014 Dec; 18(12):822-4. PubMed ID: 25538418 [TBL] [Abstract][Full Text] [Related]
5. Impact of CytoSorb and CKRT on hemodynamics in pediatric patients with septic shock: the PedCyto study. Bottari G; Guzzo I; Cappoli A; Labbadia R; Perdichizzi S; Serpe C; Creteur J; Cecchetti C; Taccone FS Front Pediatr; 2023; 11():1259384. PubMed ID: 37780052 [TBL] [Abstract][Full Text] [Related]
6. Multicentered prospective investigator initiated study to evaluate the clinical outcomes with extracorporeal cytokine adsorption device (CytoSorb Paul R; Sathe P; Kumar S; Prasad S; Aleem M; Sakhalvalkar P World J Crit Care Med; 2021 Jan; 10(1):22-34. PubMed ID: 33505870 [TBL] [Abstract][Full Text] [Related]
7. Systematic review with expert consensus on use of extracorporeal hemoadsorption in septic shock: An Indian perspective. Mehta Y; Ansari AS; Mandal AK; Chatterjee D; Sharma GS; Sathe P; Umraniya PV; Paul R; Gupta S; Singh V; Singh YP World J Crit Care Med; 2024 Mar; 13(1):89026. PubMed ID: 38633478 [TBL] [Abstract][Full Text] [Related]
8. Hemoadsorption with CytoSorb in Septic Shock Reduces Catecholamine Requirements and In-Hospital Mortality: A Single-Center Retrospective 'Genetic' Matched Analysis. Rugg C; Klose R; Hornung R; Innerhofer N; Bachler M; Schmid S; Fries D; Ströhle M Biomedicines; 2020 Nov; 8(12):. PubMed ID: 33255912 [TBL] [Abstract][Full Text] [Related]
9. Hemoadsorption by CytoSorb in septic patients: a case series. Kogelmann K; Jarczak D; Scheller M; Drüner M Crit Care; 2017 Mar; 21(1):74. PubMed ID: 28343448 [TBL] [Abstract][Full Text] [Related]
10. High-dose CytoSorb hemoadsorption is associated with improved survival in patients with septic shock: A retrospective cohort study. Schultz P; Schwier E; Eickmeyer C; Henzler D; Köhler T J Crit Care; 2021 Aug; 64():184-192. PubMed ID: 33962219 [TBL] [Abstract][Full Text] [Related]
11. Successful use of CytoSorb in a Covid-19 patient with secondary septic shock due to a sacral decubitus infection. Pancani F; Pavani R; Quacquarelli A; Feri M Int J Artif Organs; 2021 Dec; 44(12):1034-1038. PubMed ID: 33998306 [TBL] [Abstract][Full Text] [Related]
12. Immunomodulation by Hemoadsorption-Changes in Hepatic Biotransformation Capacity in Sepsis and Septic Shock: A Prospective Study. Praxenthaler J; Schwier E; Altmann S; Kirchner C; Bialas J; Henzler D; Köhler T Biomedicines; 2022 Sep; 10(10):. PubMed ID: 36289602 [TBL] [Abstract][Full Text] [Related]
14. Hemoadsorption with CytoSorb shows a decreased observed versus expected 28-day all-cause mortality in ICU patients with septic shock: a propensity-score-weighted retrospective study. Brouwer WP; Duran S; Kuijper M; Ince C Crit Care; 2019 Sep; 23(1):317. PubMed ID: 31533846 [TBL] [Abstract][Full Text] [Related]
15. Extracorporeal cytokine adsorption in septic shock: A proof of concept randomized, controlled pilot study. Hawchar F; László I; Öveges N; Trásy D; Ondrik Z; Molnar Z J Crit Care; 2019 Feb; 49():172-178. PubMed ID: 30448517 [TBL] [Abstract][Full Text] [Related]
16. Experience with hemoadsorption (CytoSorb Mehta Y; Mehta C; Kumar A; George JV; Gupta A; Nanda S; Kochhar G; Raizada A World J Crit Care Med; 2020 Jan; 9(1):1-12. PubMed ID: 32104647 [TBL] [Abstract][Full Text] [Related]
17. CytoSorb, a novel therapeutic approach for patients with septic shock: a case report. Hinz B; Jauch O; Noky T; Friesecke S; Abel P; Kaiser R Int J Artif Organs; 2015 Aug; 38(8):461-4. PubMed ID: 26349530 [TBL] [Abstract][Full Text] [Related]
18. Effects of the timing and intensity of treatment on septic shock patients treated with CytoSorb Berlot G; Samola V; Barbaresco I; Tomasini A; di Maso V; Bianco F; Gerini U Int J Artif Organs; 2022 Mar; 45(3):249-253. PubMed ID: 35075942 [TBL] [Abstract][Full Text] [Related]
19. Impact of CytoSorb Hemoadsorption Therapy on Fluid Balance in Patients with Septic Shock. Kogelmann K; Hübner T; Drüner M; Jarczak D J Clin Med; 2024 Jan; 13(1):. PubMed ID: 38202301 [TBL] [Abstract][Full Text] [Related]
20. Adjunctive Hemoadsorption Therapy with CytoSorb in Patients with Septic/Vasoplegic Shock: A Best Practice Consensus Statement. Mitzner S; Kogelmann K; Ince C; Molnár Z; Ferrer R; Nierhaus A J Clin Med; 2023 Nov; 12(23):. PubMed ID: 38068250 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]